EKF Diagnostics Holdings (LSE:EKF) Cash per Share: £0.04 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:EKF EKF Diagnostics Holdings PLC LSE:EKF
40 GF Score
Price £0.26
GF Value £0.29
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is EKF Diagnostics Holdings Cash per Share?

EKF Diagnostics Holdings LSE:EKF +1.17% 40 Cash per Share is £0.04 as of Jun. 2026. GuruFocus rates LSE:EKF with a GF Score™ of 40/100 and a GF Value™ of £0.29 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). EKF Diagnostics Holdings's Cash per Share for the quarter that ended in Jun. 2026 was £0.04.

EKF Diagnostics Holdings  (LSE:EKF) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

EKF Diagnostics Holdings Cash per Share Related Terms

EKF Diagnostics Holdings Cash per Share Historical Data

* Premium members only.

The historical data trend for EKF Diagnostics Holdings's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EKF Diagnostics Holdings Cash per Share Chart

EKF Diagnostics Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.03 0.02 0.03 0.04

EKF Diagnostics Holdings Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.03 0.04 0.04 0.04
LSE:EKF
40GF Score
EKF Diagnostics Holdings PLC LSE:EKF
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EKF Diagnostics Holdings Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

EKF Diagnostics Holdings's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=15.834/433.83
=0.04

EKF Diagnostics Holdings's Cash per Share for the quarter that ended in Jun. 2026 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=15.973/430.27
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of £0.04 mean?
EKF Diagnostics Holdings (LSE:EKF) has a Cash per Share of £0.04 as of Jun. 2026. Cash per share is the per-share value of a company's available cash. View historical data for EKF Diagnostics Holdings and its competitors.
Is EKF Diagnostics Holdings' Cash per Share too high?
EKF Diagnostics Holdings' current Cash per Share is £0.04. Overall, EKF Diagnostics Holdings has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' Cash per Share compare to ABT and SYK?
EKF Diagnostics Holdings' Cash per Share of £0.04 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Medical Devices & Instruments company?
A good Cash per Share depends on the Medical Devices & Instruments industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for EKF Diagnostics Holdings and its competitors. EKF Diagnostics Holdings's current Cash per Share is £0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (LSE:EKF) is currently considered Modestly Undervalued. The stock's GF Value™ is £0.29, compared to a current price of £0.26 — trading 10.3% below its estimated fair value. The current Cash per Share is £0.04. EKF Diagnostics Holdings' overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For EKF Diagnostics Holdings (LSE:EKF), the current Cash per Share is £0.04 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EKF Diagnostics Holdings (LSE:EKF) Overvalued in 2026?

Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued. The current stock price of £0.26 is trading 10.3% below its estimated GF Value™ of £0.29. GuruFocus considers EKF Diagnostics Holdings to be Modestly Undervalued.

Key valuation signals for LSE:EKF:

  • Cash per Share: £0.04
  • GF Value™: £0.29 vs. price of £0.26 (10.3% below fair value)
  • GF Score™: 40/100 with 4 warning signs

No single metric tells the full story. See the LSE:EKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EKF Diagnostics Holdings Business Description

Other Exchanges EKDHF:USALYF:Germany
Address 19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
40GF Score

Get the complete analysis for LSE:EKF

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.26
Price
£0.29
GF Value